Statements of Operations (Unaudited) - USD ($) |
3 Months Ended | 9 Months Ended | ||||
---|---|---|---|---|---|---|
Sep. 30, 2023 |
Sep. 30, 2022 |
Sep. 30, 2023 |
Sep. 30, 2022 |
|||
INVESTMENT INCOME | ||||||
Interest income from non-control/non-affiliate investments | $ 172,500 | $ 172,500 | $ 1,081,875 | $ 511,875 | ||
Interest income paid-in kind-from non-control/non-affiliate investments | 70,641 | 93,141 | ||||
Interest income from control investments | 266,292 | 254,679 | 781,544 | 570,415 | ||
Other income from non-control/non-affiliate investments | 3,488 | 6,064 | 4,651 | 17,996 | ||
Other income from non-investment sources | 357 | 17 | 856 | 55 | ||
Total investment income | 513,278 | 433,260 | 1,962,067 | 1,100,341 | ||
OPERATING EXPENSES | ||||||
Management fees | 76,453 | 83,014 | 238,657 | 247,395 | ||
Administration fees | 104,915 | 105,257 | 310,177 | 308,543 | ||
Audit fees | 20,800 | 21,320 | 102,336 | 128,876 | ||
Tax preparation fees | 1,570 | 13,120 | ||||
Legal fees | 37,501 | 342,598 | 148,791 | 712,909 | ||
Valuation fees | 22,500 | 28,500 | 67,500 | 94,500 | ||
Directors’ fees | 38,625 | 38,625 | 115,875 | 115,875 | ||
Insurance expense | 33,196 | 47,654 | 117,996 | 136,658 | ||
Interest expense | 1,638 | 207 | 3,963 | |||
Other general and administrative expenses | 20,362 | 35,740 | 104,395 | 80,628 | ||
Total operating expenses | 354,352 | 705,916 | 1,205,934 | 1,842,467 | ||
Net investment income (loss) before tax | 158,926 | (272,656) | 756,133 | (742,126) | ||
Income tax expense | 174 | 5,630 | 456 | |||
Net investment income (loss) after taxes | 158,752 | (272,656) | 750,503 | (742,582) | ||
Net change in unrealized gain (loss) on: | ||||||
Non-control/non-affiliate investments | (186,948) | 7,295,672 | (587,373) | 11,115,782 | ||
Control investments | (755,004) | (39,925) | 512,107 | (4,650,815) | ||
Net change in unrealized gain (loss) on investments | (941,952) | 7,255,747 | (75,266) | 6,464,967 | ||
Net increase (decrease) in net assets resulting from operations | [1] | $ (783,200) | $ 6,983,091 | $ 675,237 | $ 5,722,385 | |
Net investment income (loss) per share | ||||||
Basic (in Dollars per share) | $ 0.001 | $ (0.002) | $ 0.006 | $ (0.006) | ||
Diluted (in Dollars per share) | 0.001 | (0.002) | 0.006 | (0.006) | ||
Net increase (decrease) in net assets resulting from operations per share | ||||||
Basic (in Dollars per share) | [1] | (0.007) | 0.058 | 0.006 | 0.047 | |
Diluted (in Dollars per share) | [1] | $ (0.007) | $ 0.058 | $ 0.006 | $ 0.047 | |
Weighted average shares of common stock outstanding | ||||||
Basic (in Shares) | [1] | 120,486,061 | 120,486,061 | 120,486,061 | 120,486,061 | |
Diluted (in Shares) | [1] | 120,486,061 | 120,486,061 | 120,486,061 | 120,486,061 | |
|
X | ||||||||||
- Definition The amounts related to control investments. No definition available.
|
X | ||||||||||
- Definition The amount of income on non-control/non-affiliate investments. No definition available.
|
X | ||||||||||
- Definition Interest income paid-in kind-from non-control/non-affiliate investments. No definition available.
|
X | ||||||||||
- Definition Amount of increase (decrease) in net assets from operations of investment company. No definition available.
|
X | ||||||||||
- Definition Net increase (decrease) in net assets resulting from operations per share basic. No definition available.
|
X | ||||||||||
- Definition Net increase (decrease) in net assets resulting from operations per share diluted. No definition available.
|
X | ||||||||||
- Definition Net change in unrealized gain (loss) on control investments. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Amount of increase (decrease) in the investments in and advances to affiliates. No definition available.
|
X | ||||||||||
- Definition Other income from non-control/non-affiliate investments. No definition available.
|
X | ||||||||||
- Definition Other income from non-investment sources. No definition available.
|
X | ||||||||||
- Definition The amount of Tax preparation fees. No definition available.
|
X | ||||||||||
- Definition Amount of unrealized gain (loss) on investment. No definition available.
|
X | ||||||||||
- Definition The amount of valuation fees. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Amount of expense for administrative fee from service provided, including, but not limited to, salary, rent, or overhead cost. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The expense in the period incurred with respect to protection provided by insurance entities against risks other than risks associated with production (which are allocated to cost of sales). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of the cost of borrowed funds accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The aggregate amount of income from investments (for example, dividends) not considered a component of the entity's core operations. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of expense for investment management fee, including, but not limited to, expense in connection with research, selection, supervision, and custody of investment. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Noninterest expense related to directors' fees which are fees paid by an Entity to its directors. Directors' fees may be paid in addition to salary and other benefits. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Amount of general and administrative expense classified as other. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|